Discover the latest insights in the "Respiratory Syncytial Virus (RSV) Infections - Global Clinical Trials Review, 2025." This comprehensive report details RSV clinical trial data, including trial ...

Increases in COVID, RSV, and influenza are the result of governments refusal to enact public health measures and address ...

Many viruses circulate seasonally, picking up as the weather cools in the fall and winter. So it's true that fewer people get ...

Nirsevimab is effective for protecting infants against respiratory syncytial virus (RSV)-associated lower respiratory tract ...

The Ministry of Public Health’s latest epidemiological bulletin paints a stark picture of rising respiratory infections and a ...

Just one day after CEO Stéphane Bancel’s sudden announcement of a 10% workforce reduction, Moderna has released Q2 2025 that ...

Moderna said it would trim roughly 10 per cent of its global workforce and have fewer than 5,000 employees by the end of the ...